← Browse by Condition
Medical Condition
soft tissue sarcoma sts
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for soft tissue sarcoma sts sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — soft tissue sarcoma sts Clinical Trials
How many clinical trials are currently recruiting for soft tissue sarcoma sts?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for soft tissue sarcoma sts, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for soft tissue sarcoma sts?
soft tissue sarcoma sts research spans Phase 1 (2 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a soft tissue sarcoma sts clinical trial?
Eligibility criteria for soft tissue sarcoma sts trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06980259
Recruiting
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
Enrollment
106 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
NCT05824975 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Enrollment
358 pts
Location
United States, South...
Sponsor
GI Innovation, Inc.
NCT06889532
Recruiting
SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery
Enrollment
100 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
NCT06645808 EARLY_Phase 1
Recruiting
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
NCT06967961
Recruiting
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Enrollment
450 pts
Location
France
Sponsor
Institut Claudius Regaud
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology